Artículos de revistas
Use Of A Lactic Acid Plus Lactoserum Intimate Liquid Soap For External Hygiene In The Prevention Of Bacterial Vaginosis Recurrence After Metronidazole Oral Treatment [uso Do ácido Láctico Com Lactoserum Em Sabonete Líquido íntimo Para Higiene Externa Na Prevenção Da Recorrência De Vaginose Bacteriana Após Tratamento Oral Com Metronidazol]
Registro en:
Revista Da Associacao Medica Brasileira. , v. 57, n. 4, p. 415 - 420, 2011.
1044230
10.1590/S0104-42302011000400015
2-s2.0-80052208004
Autor
Valeria Bahamondes M.
Portugal P.M.
Brolazo E.M.
Simoes J.A.
Bahamondes L.
Institución
Resumen
Objective: To determine the recurrence of bacterial vaginosis (BV) after the use of a lactic acid plus lactoserum liquid soap starting immediately after the treatment with oral metronidazole and the quality of life of the participants. Methods: A total of 123 women with diagnosis of BV with at least three of the following criteria: 1) homogeneous vaginal discharge without inflammation of the vagina or vulva; 2) vaginal pH > 4.5; 3) positive Whiff test; and 4) clue cells in more than 20% of the epithelial cells in the vagina. A Nugent score > 4 in the vaginal bacterioscopy was also used. After BV diagnosis, metronidazole 500 mg was administered orally bid during 7 days. Patients cured of BV were then instructed to use 7.5 to 10 mL of a lactic acid plus lactoserum liquid soap once-a-day for hygiene of the external genital region. Three subsequent control visits after starting the hygiene treatment (30, 60, and 90 days; ± 5 days) were scheduled. A questionnaire was applied in the form of visual analogue scale (VAS) in all the visits regarding: 1) level of comfort at the genital region; 2) malodorous external genitalia; 3) comfort in sexual intercourse; 4) satisfaction with intimate hygiene; and 5) self-esteem. Results: Ninety two (74.8%) women initiated the use of a lactic acid plus lactoserum liquid soap at visit 1. At visit 2, 3, and 4 there were 84, 62 and 42 women available for evaluation, respectively. The rate of recurrence of BV was 19.0%, 24.2% and 7.1%, respectively in the three visits and vaginal candidiasis was observed in five treated women. Quality of life was evaluated in the 42 women who completed the four visits schedule and there were significant improvement in the five domains assessed. Conclusion: A lactic acid plus lactoserum liquid soap for external intimate hygiene may be an option for the prevention of BV recurrence after treatment and cure with oral metronidazole. © 2011 Elsevier Editora Ltda. 57 4 415 420 Hillier, S., Holmes, K.K., Bacterial vaginosis (1999) Sexually Transmitted Diseases, pp. 563-586. , In: Holmes KK, Mardh PA, Sparling PF, Lemon SM, Stamm WE, Piot P et al., editors, 3 rd ed. New York: McGraw-Hill Spiegel, C.A., Gardnerella vaginalis and Mobiluncus Species (2000) Principles and Practice of Infectious Diseases, 2, pp. 2383-2386. , In: Mandell GL, Bennett JE, Dolin R, editors, 5 th Philadelphia: Churchill Livingstone Martin, H.L., Richardson, B.A., Nyange, P.M., Lavreys, L., Hiller, S.L., Chohan, B., Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition (1999) J Infect Dis, 180, pp. 1863-1868 Guidelines for treatment of sexually transmitted diseases (1998) MMWR Morb Mortal Wkly Rep, 47 (RR-1), pp. 70-79. , Centers for Disease Control and Prevention, 1998 Livengood, C.H., Soper, D.E., Sheehan, K.L., Fenner, D.E., Martens, M.G., Nelson, A.L., Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis (1999) Sex Transm Dis, 26, pp. 137-142 Sobel, J.D., Schmitt, C., Meriwether, C., Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin (1993) J Infect Dis, 167, pp. 783-784 Boris, J., Pahlson, C., Larsson, P.G., Six years observation after successful treatment of bacterial vaginosis (1997) Infect Dis Obstet Gynecol, 5, pp. 297-302 Ferris, D.G., Francis, S.L., Dickman, E.D., Miler-Miles, K., Waller, J.L., McClendon, N., Variability of vaginal pH determination by patients and clinicians (2006) J Am Board Fam Med, 19, pp. 368-373 Soper, D.E., Gynecologic complications of bacterial vaginosis: Fact or fiction? (1999) Curr Infect Dis Rep, 1, pp. 393-397 Andersch, B., Forssman, L., Lincoln, K., Torstensson, P., Treatment of bacterial vaginosis with an acid cream: A comparison between the effect of lactate-gel and metronidazole (1986) Gynecol Obstet Invest, 21, pp. 19-25 Simoes, J.A., Discacciati, M.G., Brolazo, E.M., Portugal, P.M., Dini, D.V., Dantas, M.C., Clinical diagnosis of bacterial vaginosis (2006) Int J Gynaecol Obstet, 94, pp. 28-32 Amsel, R., Totten, P.A., Spiegel, C.A., Chen, K.C.S., Eschenbach, D., Holmes, K.K., Non-specific vaginitis. Diagnostic criteria and microbial and epidemiological associations (1983) Am J Med, 74, pp. 14-22 Nugent, R.P., Krohn, M.A., Hillier, S.L., Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation (1991) J Clin Microbiol, 29, pp. 297-301 Bradshaw, C.S., Morton, A.N., Hocking, J., Garland, S.M., Morris, M.B., Moss, L.M., High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence (2006) J Infect Dis, 193, pp. 1478-1486 Bradshaw, C.S., Tabrizi, S.N., Fairley, C.K., Morton, A.N., Rudland, E., Garland, S.M., The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy (2006) J Infect Dis, 194, pp. 828-836 Gray, R.H., Wabwire-Mangen, F., Kigozi, G., Serwadda, D., Moulton, L.H., Quinn, T.C., Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda (2001) Am J Obstet Gynecol, 185, pp. 1209-1217 Camargo, R.P., Simões, J.A., Cecatti, J.G., Alves, V.M., Faro, S., Impact of treatment for bacterial vaginosis on prematurity among Brazilian pregnant women: A retrospective cohort study (2005) São Paulo Med J, 123, pp. 108-112 Hay, P., Recurrent bacterial vaginosis (2009) Curr Opin Infect Dis, 22, pp. 82-86 Alfonsi, G.A., Shlay, J.C., Parker, S., Neher, J.O., What is the best approach for managing recurrent bacterial vaginosis? (2004) J Fam Pract, 53, pp. 650-652 CDC Sexually Transmitted Disease Treatment Guidelines 2006 (2006) MMWR Morb Mortal Wkly Rep, 55, pp. 50-52. , 2006 (2006) National Guideline For the Management of Bacterial Vaginosis, , http://www.guide-line.gov, Clinical Effectiveness Group British Association for Sexual Health and HIV, cited 2009 oct. 22. Available from Sobel, J.D., Ferris, D., Schwebke, J., Nyirjesy, P., Wiesenfeld, H.C., Peipert, J., Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis (2006) Am J Obstet Gynecol, 194, pp. 1283-1289 Holley, R.L., Richter, H.E., Varner, R.E., Pair, L., Schwebke, J.R., A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis (2004) Sex Transm Dis, 31, pp. 236-238 Boeke, A.J., Dekker, J.H., van Eijk, J.T., Kostense, P.J., Bezemer, P.D., Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: A randomized clinical trial (1993) Genitourin Med, 69, pp. 388-392 Decena, D.C.D., Co, J.T., Manalastas, R.M., Palaypayon, E.P., Padolina, C.S., Sison, J.M., Metronidazole with Lactacyd vaginal gel in bacterial vaginosis (2006) J Obstet Gynaecol Res, 32, pp. 243-251 Ness, R.B., Kip, K.E., Soper, D.E., Stamm, C.A., Rice, P., Richter, H.E., Variability of bacterial vaginosis over 6 to 12-month intervals (2006) Sex Transm Dis, 33, pp. 381-385 Ferraz do Lago, R., Simões, J.A., Bahamondes, L., Camargo, R.P., Perrotti, M., Monteiro, I., Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections (2003) Contraception, 68, pp. 105-109 Guaschino, S., Benvenuti, C., SOPHY project: An observational study of vaginal pH, lifestyle and correct intimate hygiene in women of different ages and in different physiopathological conditions (2008) Minerva Ginecol, 60, pp. 353-362. , SOPHY Study Group